- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-melanomatous Skin Cancer in United States
Total 9152 results
-
National Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Intima Bioscience, Inc.Not yet recruitingCarcinoma, Non-Small-Cell Lung | Adenocarcinoma of Lung | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Large Cell Lung CancerUnited States
-
Emory UniversityBristol-Myers SquibbWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Brown UniversityBristol-Myers SquibbRecruitingNon Small Cell Lung CancerUnited States
-
University of RochesterRecruiting
-
Albert Einstein College of MedicineCelldex TherapeuticsTerminatedLung Cancer | Non Small Cell Lung CancerUnited States
-
Loyola UniversityActive, not recruitingNon Small Cell Lung CancerUnited States
-
The University of Texas Health Science Center at...Faron Pharmaceuticals LtdWithdrawnNon-small Cell Lung CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
Jonsson Comprehensive Cancer CenterTerminatedNon Small Cell Lung CancerUnited States
-
Clovis Oncology, Inc.Genentech, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Duke UniversitySanofiTerminatedNon-small Cell Lung CancerUnited States
-
NovaRx CorporationNo longer availableNon-small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
New Mexico Cancer Care AllianceUniversity of New Mexico Cancer Center; Lovelace Respiratory Research InstituteTerminatedNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Mirati Therapeutics Inc.RecruitingResectable Non-Small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingEarly Stage Non-Small Cell Lung CancerUnited States
-
BeiGeneActive, not recruitingNSCLC | Non-small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineCompletedOligometastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Varian, a Siemens Healthineers CompanyActive, not recruitingStage III Non-small Cell Lung CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)WithdrawnStage IIIA Non-Small Cell Lung CancerUnited States
-
University of California, DavisCompletedMETASTATIC NON-SMALL CELL LUNG CANCERUnited States
-
Theresa Whiteside, PhDImmune Cell Therapy Inc.TerminatedNon Small Cell Lung Cancer (NSCLC)United States
-
ElephasBeaufort CRORecruitingNSCLC | Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Metastatic NSCLC - Non-Small Cell Lung CancerUnited States
-
Regeneron PharmaceuticalsRecruiting
-
National Cancer Institute (NCI)RecruitingAdvanced Non Small Cell Lung CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer Metastatic | Targetable Oncogenes (EGFR, ALK, ROS1)United States
-
National Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung CancerUnited States
-
Merrimack PharmaceuticalsSanofiCompletedColorectal Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Squamous Cell Head and Neck Cancer | Other Tumors With EGFR DependenceUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNSCLC | Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | NSCLC Stage IV | Non-small Cell CarcinomaUnited States
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | HER2-positive Breast Cancer | Recurrent Melanoma | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Unresectable Malignant Neoplasm | Metastatic Neoplasm | Recurrent NeoplasmUnited States
-
University of MichiganNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedBreast CancersUnited States
-
CanBas Co. Ltd.CompletedMetastatic Non-squamous Non Small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Susanne ArnoldKentucky Lung Cancer Research ProgramCompletedStage IIIB Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHead and Neck Cancer | Colorectal Cancer | Gastrointestinal Cancer | Biopsy Proven Non Small Cell Lung Cancer | Rectal Cancers | Gynecological Malignancy Requiring Definitive RadiotherapyUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
VA Office of Research and DevelopmentVA Greater Los Angeles Healthcare SystemNot yet recruitingEZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNon Small Cell Lung CancerUnited States
-
Cyclacel Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesTerminatedNon-small Cell Lung CancerUnited States
-
University of UtahBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedNon-Small-Cell Lung CancerUnited States
-
Tocagen Inc.TerminatedMelanoma | Sarcoma | Lymphoma | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | IDH1 Mutated Solid Tumors | IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)United States
-
Nerissa T. ViolaNot yet recruitingNon Small Cell Lung CancerUnited States
-
Carevive Systems, Inc.CompletedNon Small Cell Lung CancerUnited States